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Expression of the cyclin kinase inhibitor, p27kip1, in developing and
mature human kidney. It has been shown that glomerular visceral
epithelial cells (VEC) proliferate during glomerulogenesis, but differen-
tiated VEC of the fetal kidney do not. It is also recognized that the
proliferative capacity of the VEC in mature kidneys is very limited, and,
according to some investigators, may be completely absent. The basis for
this remains unknown. Cell proliferation is controlled by cell cycle-related
proteins, of which one class, the cyclin kinase inhibitors (CKI), cause cell
cycle arrest and inhibit proliferation. A role for CKI in kidney develop-
ment is not known. Accordingly, we examined the expression of the CKI
p27kip1 (p27) in developing and mature human kidney tissue. Concomitant
expression of markers of cell proliferation, Ki-67-related antigen (Ki-67)
and proliferating cell nuclear antigen (PCNA), also were examined in fetal
and mature human kidney tissue by immunocytochemical techniques. In
developing kidney, Ki-67 and PCNA expression are most pronounced in
the nephrogenic zone where expression correlates inversely with increas-
ing glomerular maturation. In well-differentiated glomeruli, Ki-67 and
PCNA expression is present in some parietal epithelial cells but is absent
in the VEC. In contrast, p27 staining exhibits a reverse gradient of
expression. p27 is absent in the proliferating tissue exhibiting the earliest
stages of differentiation, whereas expression is widespread in the differ-
entiated epithelial cells of more mature glomeruli, in which detectable cell
proliferation has ceased. Expression of p27 was not identified in fetal
mesangial or glomerular endothelial cells. In the mature human kidney,
the pattern of p27 expression identified in differentiated fetal glomeruli
persists and appears to be constitutive and specific for glomerular VEC.
This pattern of p27 expression in terminally differentiated VEC may
explain their limited proliferative capacity in response to injury. This is the
first demonstration of a potential role for p27 in human renal develop-
ment.
The capacity of the glomerular visceral epithelial cell (VEC) or
podocyte to undergo cell proliferation is a question of great
current interest. There are studies in human and experimental
animals that suggest that these cells have the capacity to enter the
cell cycle by virtue of their ability to incorporate tritiated thymi-
dine [1], by the demonstrated expression of the cell cycle-
associated proteins proliferating cell nuclear antigen (PCNA) and
Ki-67-related antigen (Ki-67) in these cells [2–4], and by the
recognition of mitotic figures in these cells at sites of apparent
epithelial cell prominence or possibly increased cell number [2, 5].
Other studies suggest that VEC may lack the capacity to undergo
complete cell division [reviewed in 6, 7]. While acknowledging
that these cells may traverse early steps through the cell cycle,
some investigators suggest that VEC lack the ability to undergo
full cytokinesis/cell division, and as evidence demonstrate the
presence of multinucleated podocytes and an inability to demon-
strate increased cell numbers after a variety of injuries have been
administered to these cells [8–11]. Studies in experimental models
of VEC injury indicate that the inability of VEC to undergo
adequate proliferation following injury, in conjunction with de-
tachment from the glomerular capillary basement membranes, is
a critical step in the development of the lesion of focal and
segmental glomerular sclerosis [6–8, 11].
Cell proliferation is controlled by cell cycle regulatory proteins.
Progression through the cell cycle requires that cyclin dependent
kinases (CDK) be activated by cyclins [12]. Two families of cyclin
kinase inhibitors (CKI) inactivate target CDK’s, thereby arresting
the cell cycle and inhibiting proliferation. The CKI p27 inhibits
cyclin-CDK complexes in both G1 and S phase of the cell cycle.
We have shown that mesangial cell proliferation is determined by
the levels of p27 [13], but its role in the VEC remains to be fully
elucidated.
Glomerulogenesis in the developing fetal metanephric kidney
affords an excellent opportunity to examine how specific cell cycle
regulatory proteins may participate in the control of cell prolifer-
ation. A well-characterized sequence of events, beginning with a
stage of widespread, even uniform, proliferation of the immature
epithelial structures differentiating from metanephric blastema,
culminates in differentiated glomeruli, where proliferation of
VEC essentially ceases [14, 15]. We therefore examined how the
expression of p27 in developing metanephric human kidney
tissues might be reflected in these established patterns of cell
proliferation. Our studies demonstrate strong and uniform ex-
pression of p27 in differentiated glomerular VEC. The de novo
expression of p27 corresponds to the stage of development where
proliferation of differentiating epithelium ceases and differentia-
tion into the specific podocyte phenotype occurs. This specific
pattern of p27 in fetal VEC, in contrast with all other glomerular
cell types examined in the developing kidney, persists into adult-
hood. The localization of p27 to this highly differentiated cell type
may explain, at least in part, the low proliferative capacity of the
mature VEC.
1 See Editorial by Wolf and Neilson, p. 1087
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METHODS
Source of tissue
Human fetal kidneys with estimated gestational age ranging
from 54 to 104 days (N 5 26) were obtained fresh from tissue
examined after therapeutic abortions. Eleven of the samples
(estimated gestational age ranging from 56 to 81 days) were fixed
in 10% neutral buffered formalin and then processed and embed-
ded in paraffin according to conventional techniques. Fifteen
kidneys (estimated gestational ranging from 54 to 105 days) were
fixed in methyl Carnoy’s solution (60% methanol, 30% chloro-
form, and 10% acetic acid) and processed and embedded in
paraffin. Mature human kidney was obtained from fresh tissue
examined after nephrectomy (N 5 17). All of these samples were
fixed in 10% neutral buffered formalin and processed and em-
bedded in paraffin.
Antibodies
p27 kip1 (p27). p27 (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA, USA) is an affinity-purified goat polyclonal antibody raised
against a peptide corresponding to amino acids 181-298 mapping
at the carboxy terminus of p27 of human origin. Its specific
recognition of p27 has been demonstrated previously by both
Western blotting [16] and immunoprecipitation [17] techniques.
Ki-67 related antigen (Ki-67). MIB-1 (Coulter/Immunotech,
Miami, FL, USA) is a purified murine monoclonal IgG antibody
raised against a peptide corresponding to a 1002 base pair
sequence of Ki-67-related antigen cDNA [18]. Specificity of this
antibody to Ki-67 antigen, a human nuclear cell proliferation-
associated antigen, has been demonstrated by Western blotting
[18, 19] and immunohistochemistry [18, 20].
PCNA. A murine monoclonal antibody to PCNA/cyclin, 19A2
(Coulter Corp., Hialeah, FL, USA) has been well characterized
and was used in methyl Carnoys’ fixed tissues as previously
described [21, 22].
Immunohistochemistry
Formalin-fixed tissue sections (used for immunohistochemistry
studies of p27 and Ki-67) were deparaffinized with xylene and
rehydrated with graded ethanols. Endogenous peroxidase was
blocked with hydrogen peroxide and the samples were then rinsed
in PBS. To obtain an adequate signal with the p27 antibody, the
slides were heated for 30 minutes in a pressure cooker in Antigen
Unmasking Solution (Vector Laboratories, Burlingame, CA,
USA). To reduce background, the sections to be stained for p27
were blocked for 30 minutes in 10% normal rabbit serum. The
sections were then incubated with p27 or MIB-1 primary antibody
diluted in PBS containing 1% bovine serum albumin for one hour
at room temperature. After PBS washes, the tissue was incubated
sequentially with biotinylated secondary antibody, avidin-biotin-
peroxidase complex (ABC-Elite; Vector Laboratories) and then
3,39-diaminobenzidine (with nickel chloride enhancement) to give
a black reaction product. The tissue sections were counterstained
with methyl green, dehydrated and coverslipped.
Methyl Carnoy’s fixed tissue sections (used for immunohisto-
chemistry studies of PCNA) were deparaffinized, rehydrated,
blocked with hydrogen peroxide, and washed with phosphate
buffered saline (PBS). The tissue sections were then incubated
with anti-PCNA antibody and processed as above. Controls for all
of the immunocytochemistry included substitution of the primary
antibody with normal IgG from the same species as the primary
antibody at a similar concentration.
RESULTS
Fetal kidney tissue was obtained with gestational ages ranging
from 54 to 105 days. The tissue sample exhibited age-appropriate
structures, including undifferentiated blastema and early glomer-
ular vesicles at the outer margin of the cortex, comma and S-stage
glomeruli beneath the outer cortex, and more mature glomeruli in
the inner cortex.
Immunohistochemistry
Ki-67. Expression of the proliferation marker Ki-67 was most
pronounced in the nephrogenic zone in the first stages of glomer-
ular epithelial differentiation, where many cells in differentiating
vesicles and folding, developing glomeruli (“comma” shaped
glomeruli) were actively replicating (Fig. 1A). The S-shaped
glomeruli exhibited varying expression of Ki-67, but generally
there was decreasing Ki-67 expression corresponding to a pro-
gressively greater glomerular maturation. In well-differentiated
glomeruli, Ki-67 expression was uniformly undetectable in VEC
(Fig. 1B). At the stage of full glomerular differentiation, scattered
non-uniform Ki-67 staining was present in some parietal epithelial
cells and within the glomerular tuft in locations corresponding to
expression by mesangial or endothelial cells. More specific iden-
tification of the scattered, occasionally positive cells was not
achieved by histologic examination.
PCNA. As described and illustrated previously [14], PCNA
expression was most heavily concentrated in the nephrogenic zone
with a declining gradient as glomerular maturation increased (Fig.
1). The pattern of Ki-67 antigen and PCNA expression were
essentially indistinguishable within glomeruli at all stages of
differentiation (Fig. 1A, 1G).
p27. Staining for the CKI p27 in fetal tissue exhibited a gradient
of expression with absence in the least differentiated structures to
most abundant staining in fully differentiated glomeruli (Fig. 1 C,
D). The undifferentiated metanephric blastema, ureteric buds,
and early glomerular vesicles of the subcapsular cortex showed no
expression of p27. As folding of the vesicular structures com-
menced (“comma shaped” glomeruli), focal and weakly detect-
able p27 expression was identified in individual cells, and this
expression extended to a greater proportion of the epithelial cells
in conjunction with further differentiation to the phase of S-
shaped glomeruli (Fig. 1 C, E). When the glomerulus is fully
differentiated, VEC uniformly exhibit p27 expression with strong
immunohistochemical staining (Fig. 1 D, F). No expression is
identified in mesangial or endothelial cells. Thus, staining for p27
and markers of DNA synthesis (PCNA, Ki-67) did not co-localize.
In adult kidney tissue, p27 expression was found constitutively and
generally uniformly in glomerular visceral epithelium and in some
parietal epithelial cells (Fig. 1H). In contrast, mesangial and
endothelial cells did not exhibit detectable p27 expression.
DISCUSSION
Our study is the first demonstration of the expression of one
class of cell cycle regulatory proteins, CKI, in human kidney. We
show that constitutive expression of the CKI p27 is restricted to
differentiated glomerular VEC, and that the de novo expression of
p27 corresponds with the transition of the proliferating immature
VEC to mature, non-proliferating VEC.
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There are several lines of evidence to show that the CKI p27
controls cell proliferation. The overexpression of p27 in cultured
cells causes cell cycle arrest, whereas lowering p27 levels increases
proliferation both in renal (mesangial) and non-renal cells in
culture [13, 24]. Recent studies have demonstrated that p27
expression may be an important determinant of renal cell prolif-
eration in several in vivo models of renal disease. In the Thy 1
model of mesangial proliferative glomerulonephritis, the onset of
mesangial cell proliferation coincides with a decrease in p27 levels
and cessation of proliferation coincides with increasing p27 levels
as they return to normal patterns [25]. More recently, we have
shown that injury to the VEC in the passive Heymann nephritis
model of membranous nephritis is associated with increased levels
of this CKI [26]. Finally, it has also been shown that p27 knockout
mice exhibit widespread organ hypercellularity, but are otherwise
architecturally normal, indicative of a generalized defect in regu-
lation of cell number. This is presumed to be the result of altered
regulation of cell proliferation [27]. The p27 knockout mouse
specifically exhibits normal architectural organization of the glo-
merulus as assessed histologically and by ultrastructural strudies
(C.E. Alpers, personal observations).
The present study extends these previous studies of p27 in
cultured cells and in experimental models of renal disease to
human kidneys and correlates p27 levels with defined patterns of
cell proliferation. In this study, we demonstrated patterns of
expression of Ki-67 and PCNA, both markers of cell proliferation,
at stages of glomerulogenesis (vesicular transformation of epithe-
lial cell progenitors from the metanephric blastema, enlargement
of the epithelial cell mass through the folding stages–comma and
S-shape–of early glomerular development) previously demon-
strated to have features of extensive cell proliferation [14, 23].
There is decreasing expression of these markers of proliferation
with terminal differentiation of the glomerulus. The absence of
these cell proliferation markers in mature VEC supports the
concept that these cells do not, in general, replicate after terminal
differentiation [2, 5].
The developing kidney, with these defined stages of cell prolif-
eration, is therefore an excellent organ to evaluate the possibility
that p27 is important in determining the replicative capacity of
specific renal cell types and the VEC in particular. This study
found that p27 is first detectable at that stage in glomerulogenesis
when cell proliferation diminishes, and its uniform expression
occurs in a cell type long recognized to have the least proliferative
potential of any renal parenchymal cell [3]. Together, these
findings provide substantial support for the concept that p27 is an
important negative regulatory molecule for VEC replication. The
persistent and constitutive expression of p27 in the normal adult
kidney offers one mechanism to explain the limited capacity for
replication of these cells. It does not, however, explain the failure
to complete cytokinesis by these cells that is observed in some
experimental settings [7, 11], since this process occurs later in the
cell cycle than the G1 to S transition regulated by p27.
The finding that p27 was not expressed in undifferentiated
blastemal cells, while increasing in conjunction with the acquisi-
tion of podocyte phenotype, is consistent with the possibility that
this CKI also may function to promote and/or maintain cell
differentiation in some cell types, independent of its defined role
in regulation of cell proliferation [28]. This possibility is strength-
ened by p27’s continued expression in mature VEC. The factors
that regulate this p27 expression in VEC are not known. In
non-renal cells, it is known that p27 is post-translationally modi-
fied by the ubiquitin—proteasome pathway [29]. It remains to be
established if this pathway is also relevant to renal cell types.
VEC injury is central in many forms of human renal disease,
including glomerulonephritis, membranous nephropathy minimal
change disease, and collapsing and HIV-associated nephropathy.
It can be hypothesized that if p27 expression is not downregu-
lated, as exemplified during the early proliferative stages of
glomerulogenesis, the proliferative capacity of the VEC remains
in check even in the face of tissue injury. Such a scenario could
then lead to a progressive injury process similar to that identified
in the partial ablation [9], ablation/hypertension [10], and Masugi
nephritis [29] models in rodents whereby injured VEC, detached
from the capillary basement membrane and unable to undergo
replication, result in leaving a denuded glomerular basement
membrane. This in turn would contribute to protein leak into the
urinary space, synechial attachment to Bowman’s capsule, and
eventually to segmental sclerosis. Alternately, it can be hypothe-
sized that if p27 expression can be downregulated under certain
conditions, it might help to explain the accumulation of epithelial
Fig. 1. (A.) Expression of the cell proliferation marker, Ki-67-related antigen, in human fetal kidney of 67 days gestation. There is widespread
proliferation of cells, indicated by dark staining nuclei, in a zone of nephrogenesis immediately under the renal capsule, which involves blastemal cells,
vesicles, and folding epithelial structures corresponding to the earliest stages of glomerulogenesis. The zone of cell proliferation is sharply demarcated,
with only scattered proliferating cells present in the remaining portions of the renal parenchyma. Expression of PCNA was indistinguishable from that
illustrated here. (B.) Higher power view of kidney in A showing widespread expression of Ki-67-related antigen in tubular structures in regions closest
to the renal capsule (top), with scattered expression of this antigen in more differentiated renal cells (bottom of photo) that is not linked to any specific
differentiating cell type. There is a transition (arrowheads) where folding, differentiating glomeruli exhibit an intermediate pattern of expression of
Ki-67-related antigen indicating some, but not all, of the cells in these structures are still engaged in cell cycle traverse. A more differentiated glomerulus
(arrow) is notable for absence of clearly detectable Ki-67-related antigen expression in the great majority of cells present, including visceral epithelial
cells. (C.) Expression of p27 in a sequential tissue section from the same kidney as A and B. Expression of p27, indicated by darkly stained nuclei, is
largely confined to the VEC of differentiating glomeruli, and is absolutely distinct from the pattern of cell proliferation demonstrated in A. (D.) Higher
power view of kidney in C, showing a field matching that illustrated in B, stained to demonstrate expression of p27. The early differentiating epithelial
structures do not express p27, while differentiated glomerular VEC do (arrows). Again, the point of transition where cells cease to express markers of
proliferation, as illustrated in B, marks the earliest stage of glomerulogenesis where p27 expression can be identified (arrowheads). (E.) Example of the
earliest stage at which p27 first becomes detectable in the differentiating epithelium of a folding, developing glomerulus. The metanephric blastema and
great majority of interstitial cells do not express this molecule. p27 expression is detectable in some tubular structures, also evidenced in Figure 1C and
D. (F.) p27 is uniformly expressed by differentiated VEC in developing glomeruli. (G.) Expression of PCNA in a human fetal kidney of 73 days gestation.
The pattern of staining is indistinguishable from that of Ki-67 (Fig. 1A), although the immunohistochemical stains achieved with this antibody are less
intense than those obtained with the Ki-67 antibody. (H.) Constitutive expression of p27 in VEC, but not other cell types, of adult human kidney. There
is persistence of the pattern of expression identified in differentiated fetal glomeruli, as illustrated in Figure 1F.
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cells that is a feature of some diseases such as collapsing and
HIV-associated nephropathy. It will be important to examine
multiple examples of glomerular diseases associated with VEC
injury for expression of relevant cell cycle regulatory proteins in
order to test this hypothetical sequence of injury.
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APPENDIX
Abbreviations used in this article are: ABC, avidin-biotin-peroxidase
complex; CDK, cyclin dependent kinases; CKI, cyclin kinase inhibitors;
KI-67, Ki-67-related antigen; p27, cyclin kinase inhibitor p27kip1, PCNA,
proliferating cell nuclear antigen; VEC, visceral epithelial cells.
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